Dubai's Histopathology & Specialty Laboratory (HSL) - part of Gulf Healthcare
International's Medsol network of laboratories - has introduced a new line of
testing for Human papillomavirus 'HPV'. HSL is the first regional private sector
lab to introduce the new service in house.
HPVs are a group of more than 100 related viruses and some types of HPV -
high-risk, oncogenic, or carcinogenic HPVs - are associated with certain types
of cervical cancer in women. While most HPV infections occur without any
symptoms, HPV infection sometimes persists for many years and can increase the
risk of developing cervical cancer.
The new testing process is combined with HSL's Liquid Base Cytology service (for
cervical screening) and enables the clinician to request HPV typing as well from
the same specimen, promoting easier diagnosis.
Dr. Samar Hourieh, MD, director of Histopathology and Specialty Laboratory said:
"The new HPV test is an important step for identifying and treating cervical
cancer, as well as raising awareness and improving women's health across the
MENA region."
Established in 2000, HSL offers comprehensive and high quality Histopathology
and Cytology services in the private sector.
